FDA Inspection 862071 — Greater Baltimore Medical Center

Greater Baltimore Medical Center — FEI 1173170

The FDA completed an inspection of Greater Baltimore Medical Center on January 15, 2014 in Towson, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 15, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Towson, MD (United States)